Tetracosactide Acetate for Injection 0.25mg (Cortrosyn® / コートロシン注射用0.25mg)

JPY ¥4,400

Japanese Synthetic ACTH Preparation (Tetracosactide Acetate 0.25mg). Lyophilized powder for intramuscular, intravenous, or intravenous drip infusion for adrenocortical function testing. 0.25mg x 1 vial (with 1 ampule of Sodium Chloride Injection JP 2mL). Mfd. by Alfresa Pharma Corporation, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥4,048
10 - 19 12% JPY ¥3,872
20 + 18% JPY ¥3,608
SKU: CRT-025-INJ Category:

Description

Product Overview / 商品概要

Cortrosyn for Injection 0.25mg (コートロシン注射用0.25mg)
Generic: Tetracosactide Acetate / テトラコサクチド酢酸塩
Therapeutic Category: Synthetic ACTH Preparation / 合成ACTH製剤
Manufactured by: Alfresa Pharma Corporation / アルフレッサ ファーマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Tetracosactide Acetate 0.28mg (equivalent to Tetracosactide 0.25mg) per vial / 1バイアル中 テトラコサクチド酢酸塩 0.28mg(テトラコサクチドとして0.25mg)
Additives: D-Mannitol 10mg per vial / D-マンニトール 10mg(1バイアル中)
Appearance: White mass or powder, lyophilized powder for injection to be reconstituted before use. pH 6.0–7.0 (after reconstitution with attached solvent), osmolarity ratio (vs. normal saline) 1.0–1.2 (after reconstitution with attached solvent)
外観: 白色の塊又は粉末、用時溶解して用いる凍結乾燥注射剤。pH 6.0〜7.0(添付溶解液で溶解後)、浸透圧比(生理食塩液対比)1.0〜1.2(添付溶解液で溶解後)

Indications / 効能効果

EN: Adrenocortical function testing
JA: 副腎皮質機能検査

Dosage and Administration / 用法用量

EN: Reconstitute with the attached solvent and administer once daily as follows; may be repeated for 2–3 consecutive days if necessary. For intramuscular or intravenous injection: use 0.25mg as tetracosactide. For intravenous drip infusion: add 0.25–0.5mg as tetracosactide to 5% glucose injection, normal saline, water for injection, etc., and infuse intravenously over 4–8 hours.
JA: 1日1回添付溶解液に溶解し、下記量を使用する。必要があれば連続2〜3日行う。○筋注・静注には、テトラコサクチドとして0.25mgを使用する。○点滴静注にはテトラコサクチドとして0.25〜0.5mgを5%ブドウ糖注射液、生理食塩液、注射用水などに加え、4〜8時間点滴静脈内注入する。

Contraindications / 禁忌

EN: No contraindications explicitly stated in the package insert
JA: 添付文書に明示された禁忌の記載なし

Regulatory Information / 規制情報

Approval No.: 22100AMX00731
Sales Started: June 1970 / 1970年6月
Classification Code: 872411
Storage: Store in a cool place / 冷所保存
Shelf Life: 36 months / 36ヵ月

Packaging / 包装

Main Package (for sale): 0.25mg x 1 vial (with 1 ampule of Sodium Chloride Injection JP 2mL) / 0.25mg[1バイアル](溶解液:日局生理食塩液2mL 1アンプル添付)
Other Available Packages (by special order): 0.25mg [1 vial] (with 1 ampule of Sodium Chloride Injection JP 2mL as solvent)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Tetracosactide Acetate for Injection 0.25mg (Cortrosyn® / コートロシン注射用0.25mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Tetracosactide Acetate for Injection 0.25mg (Cortrosyn®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.